About Equinox Equinox Group Principals What We Do
Disease Target Assessment

Disease Target Assessment (DTA) tools help disease area strategy and business development teams ensure they are pursuing products that offer significant clinical advantage and commercial potential.

DTA Tools:

  • Characterize overall unmet need in an indication given the current standard of care
  • Benchmark target product profiles against current and future standards of care
  • Generate an early read on the level of clinical innovation and potential for commercial success, including reimbursement outlook
Discovery Scan

Discovery Scan is a streamlined tool designed to quickly analyze and select candidate diseases for drug discovery or business development. It measures the level and nature of unmet need across a wide range of indications, and provides a consistent approach that supports valid comparison of opportunities across diseases. Based on objective, rigorous methods that have been applied and refined for more than 16 years, Discovery Scan has been used successfully to analyze hundreds of diseases across all therapeutic areas.
Forecasting Solutions

Equinox Group, a leader in the art of new drug forecasting, places special emphasis on product and total market forecasting. Our patient-based forecast models offer unique features. They allow users to:

  • Generate patient shares based on a valid and transparent forecast engine
  • See instantly how shares change with new information about attributes, launch dates, price, and competitors
  • Calibrate to audit data to ground projections in reality
Focused Market Research

Being forecasting experts, Equinox Group designs its market research studies primarily to support new product forecasts. Our studies also provide support for complex patient-flow epidemiology assumptions that are difficult or impossible to find elsewhere, while our conjoint simulators drive to patient share rather than to ambiguous preference shares. We pride ourselves on customizing analyses and presentations for each client.
Patient Mapping

Equinox Group’s patient flow maps quantify the number of patients at critical points in the diagnosis, treatment, and referral process. Geared to enhance marketing efforts, they allow users to:

  • Estimate the number of patients in each disease phase and track treatment histories
  • Understand in detail likely sources of business for a new product
  • Identify leverage points to focus marketing activity
  • Model interactions among multiple assets in a single market